Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 856 AL 870

From Mechanisms to Medicine: Astrocyte Dysfunction in Stress-Related Neuroinflammation and Alzheimer's Disease

Gupta KR, Thombre KR, Umekar MJ.

Eur J Neurosci. 2026 Apr;63(7):e70508. doi: 10.1111/ejn.70508.

Advances in the drug treatment of Alzheimer's disease: pathophysiology and mechanisms of action

Nowell J, Crook H, de Leon MJ, Edison P.

BMJ. 2026 Apr 20;393:78881. doi: 10.1136/bmj-2023-078881.

From Lipids to Mitochondria: Shared Metabolic Alterations in Obesity and Alzheimer's Disease

Uranga RM, Allani SK.

Cells. 2026 Apr 10;15(8):672. doi: 10.3390/cells15080672.

Gut Microbiota Dysbiosis and Neuroinflammation in Alzheimer's Disease: a Systematic Review of Mechanistic Insights

Katsigianni S, Koutsouraki E.

Mol Neurobiol. 2026 May 12;63(1):623. doi: 10.1007/s12035-026-05914-9.

FOXO transcription factors in Alzheimer's Disease: balancing neuroprotection and neuronal degeneration

Shyam M, Veronica A, Wadhwa J, Sharma V, B M O, Srirangan P, Venkatesh R, Evan Prince S.

Mol Biol Rep. 2026 May 26;53(1):833. doi: 10.1007/s11033-026-12021-4.

The role and therapeutic potential of DNA glycosylases in Alzheimer's disease

Zhao X, Li Y, Meng Z, Xu X, Chen L, Yu Q, Wang R, Ren Y, Chen F, Ai Q, Deng Y, Yu H, Wei J, Liang G.

Ageing Res Rev. 2026 Jun;118:103129. doi: 10.1016/j.arr.2026.103129. Epub 2026 Apr 10.

Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1(Glu280Ala) mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial

Tariot PN, Lopera FS, Ríos-Romenets S, Sink KM, Giraldo-Chica M, Acosta-Baena N, Villegas G, Espinosa A, Castaño ML, Muñoz C, Ospina P, Bocanegra Y, Tirado V, Henao E, Cardona E, Luna E, Lopez H, Sánchez G, Collazos MM, Alvarez S, Aguillón D, Hu N, Clayton D, Bittner T, Schneider A, Dolton M, Poon V, Nguyen J, Thomas RG, Schneider LS, Chen K, Su Y, Alexander RC, Quiroz YT, Cai Y, Xu YR, Ostaszewski B, Selkoe DJ, Ashton NJ, Denkinger MN, Jakimovich LJ, Doody RS, Langbaum JB, Reiman EM.

Lancet Neurol. 2026 Feb;25(2):147-159. doi: 10.1016/S1474-4422(25)00426-0.

Modeling sporadic Alzheimer's disease using brain organoids: Emerging trends and translational opportunities

Hossain MK, Kim HR.

Tissue Cell. 2026 Aug;101:103443. doi: 10.1016/j.tice.2026.103443. Epub 2026 Mar 7.

Elucidating the molecular targets in Alzheimer's disease: Advances and therapeutic implications

Soni U, Pujari R.

Prog Neuropsychopharmacol Biol Psychiatry. 2026 Apr 2;146:111660. doi: 10.1016/j.pnpbp.2026.111660. Epub 2026 Mar 6.

Regulation of autophagy-mediated pathways by diet, physical activity, and sleep in Alzheimer's disease

Ariyath A, Mputhia Z, Dougherty C, Rahuman BK, Fernando WMADB, Brown B, Gardener SL, Rainey-Smith SR, Martins R, Bharadwaj P.

Alzheimers Dement. 2026 Feb;22(2):e71191. doi: 10.1002/alz.71191.

Interplay between Peripheral and Central Nervous System Myeloid Cells during Aging: Impact for Lade-Life Depression and Alzheimer's Disease

Silva de Miranda A, Vieira ÉLM, Teixeira AL, Bauer ME.

Neuroimmunomodulation. 2026;33(1):101-124. doi: 10.1159/000550781. Epub 2026 Feb 5.

TREM2 as a possible link between Alzheimer's disease and diabetes mellitus

Chen W, Huang N, Huang W, Wang M, Luo Y, Huang J.

Exp Neurol. 2026 Jul;401:115739. doi: 10.1016/j.expneurol.2026.115739. Epub 2026 Mar 19.

Natural Chiral Scaffolds in Alzheimer's Disease: Therapeutic Potential, Mechanism, and Clinical Aspects

Singh A, Sahu SK, Sah AK.

Biomed Res Int. 2026;2026(1):e5968529. doi: 10.1155/bmri/5968529.

Review of Donanemab and Lecanemab in Mild Dementia Stage of Alzheimer's Disease: Progress and Challenges

Qudoos MA, Elliott DP.

Sr Care Pharm. 2026 Apr 1;41(3):98-108. doi: 10.4140/TCP.n.2026.98.

Overcoming the blood‒brain barrier: nanomedicine strategies for targeted delivery and multimodal therapy in Alzheimer's disease

Li J, Guo L, Cai W, Mei J, Liu J, Liu Y.

Drug Deliv. 2026 Dec 31;33(1):2645830. doi: 10.1080/10717544.2026.2645830. Epub 2026 Mar 20.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias